Solasto (TSE:6197) Beta: -0.1784 (As of Jun. 27, 2026)


TSE:6197 Solasto Corp TSE:6197
58 GF Score
Price 円1,109.00
GF Value 円563.54
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Solasto Beta?

Solasto TSE:6197 58 Beta is -0.1784 as of Jun. 27, 2026. GuruFocus rates TSE:6197 with a GF Score™ of 58/100 and a GF Value™ of 円563.54 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-27), Solasto's Beta is -0.1784.


Solasto  (TSE:6197) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Solasto Beta Related Terms


Solasto Beta Historical Data

* Premium members only.

The historical data trend for Solasto's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Solasto Beta Chart

Solasto Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.99 1.26 0.61 0.31 -0.20

Solasto Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.31 0.29 0.28 -0.05 -0.20

TSE:6197 vs HCA, THC, DVA: Beta Comparison

For the Medical Care Facilities subindustry, Solasto's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Solasto Beta vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Solasto's Beta distribution charts can be found below:

* The bar in red indicates where Solasto's Beta falls into.


TSE:6197
58GF Score
Solasto Corp TSE:6197
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Solasto Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of -0.1784 mean?
Solasto (TSE:6197) has a Beta of -0.1784 as of Jun. 27, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Solasto and its competitors.
Is Solasto's Beta too high?
Solasto's current Beta is -0.1784. Overall, Solasto has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Solasto's Beta compare to HCA and THC?
Solasto's Beta of -0.1784 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Healthcare Providers & Services company?
A good Beta depends on the Healthcare Providers & Services industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Solasto and its competitors. Solasto's current Beta is -0.1784. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Solasto stock overvalued right now?
Based on GuruFocus' analysis, Solasto (TSE:6197) is currently considered Significantly Overvalued. The stock's GF Value™ is 円563.54, compared to a current price of 円1,109.00 — trading 96.8% above its estimated fair value. The current Beta is -0.1784. Solasto's overall GF Score™ is 58/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Solasto (TSE:6197), the current Beta is -0.1784 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Solasto (TSE:6197) Overvalued in 2026?

Based on GuruFocus' analysis, Solasto stock appears to be overvalued. The current stock price of 円1,109.00 is trading 96.8% above its estimated GF Value™ of 円563.54. GuruFocus considers Solasto to be Significantly Overvalued.

Key valuation signals for TSE:6197:

  • Beta: -0.1784
  • GF Value™: 円563.54 vs. price of 円1,109.00 (96.8% above fair value)
  • GF Score™: 58/100 with 7 warning signs

No single metric tells the full story. See the TSE:6197 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Solasto Business Description

Address 1-7-18 Konan, Minato-ku, Tokyo, JPN, 108-8210
Solasto Corp is engaged in providing medical outsourcing business, long-term care and child care business and others.
58GF Score

Get the complete analysis for TSE:6197

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,109.00
Price
円563.54
GF Value